3rd Quarter - Report

CVS HEALTH (AND SUBSIDIARIES) for CVS HEALTH (AND SUBSIDIARIES)

Firm
Client
Income
—
Expenses
$2,150,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to retail pharmacy, drug pricing, and women's health. H.R. 3164 - The Ensuring Community Access to Pharmacist Services Act of 2025 S. 2426 - The Equitable Community Access to Pharmacist Services Act P.L. 119-21 - The One Big, Beautiful Bill Act - issues related to retail pharmacy

LobbyistCovered position, as disclosed
NICOLE BURDA —
JOY MCGLAUN —
SHANNON PENBERTHY —
KATHERINE RAAB New Senior Legislative Aide, Rep. Mary Bono; Professional Staff Member, House Energy and Commerce Committee
AMY ROSENBAUM —
TARA ROUNTREE —
ROBERT TANNER WARBINTON —

Contacted: Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 2426 (119th), H.R. 3164 (119th)

Taxation/Internal Revenue Code TAX

Issues related to corporate tax. P.L. 119-21 - The One Big, Beautiful Bill Act H.R. 3010/S. 1785 - No Handouts for Drug Advertisement Act

LobbyistCovered position, as disclosed
SHANNON PENBERTHY —
MELISSA SCHULMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 1785 (119th), H.R. 3010 (119th)

Medicare/Medicaid MMM

Issues related to Medicare Part D, Medicare Advantage, Medicaid, mental health, and telehealth. Issues related to pharmacy testing, vaccination, and treatment. Issues related to Accountable Care Organizations. Issues related to Medicare Shared Savings Program. Issues related to Medicaid. S. 882, The Patients Before Middlemen (PBM) Act S. 927, The Protecting Pharmacies in Medicaid Act S. 1105 - No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act P.L. 119-21 - The One Big, Beautiful Bill Act - - issues related to Medicaid and PBMs H.R. 4317, The Pharmacy Benefit Manager (PBM) Reform Act

LobbyistCovered position, as disclosed
NICOLE BURDA —
JOY MCGLAUN —
SHANNON PENBERTHY —
KATHERINE RAAB New Senior Legislative Aide, Rep. Mary Bono; Professional Staff Member, House Energy and Commerce Committee
AMY ROSENBAUM —
TARA ROUNTREE —
MELISSA SCHULMAN —
ROBERT TANNER WARBINTON —

Contacted: White House Office; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 927 (119th), S. 1105 (119th), H.R. 4317 (119th), S. 882 (119th)

Insurance INS

Issues related to employer, small group and individual insurance markets. H.R. 2214, the Delinking Revenue from Unfair Gouging (DRUG) Act P.L. 119-21 - The One Big, Beautiful Bill Act H.R. 5433 - The Patients Over Profits Act S. 2836 - The Patients Over Profits Act H.R. 4409 - The Fair Pharmacies for Federal Employees Act of 2025

LobbyistCovered position, as disclosed
JOY MCGLAUN —
SHANNON PENBERTHY —
AMY ROSENBAUM —
TARA ROUNTREE —
MELISSA SCHULMAN —
ROBERT TANNER WARBINTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2836 (119th), H.R. 2214 (119th), H.R. 4409 (119th), H.R. 5433 (119th)

Labor Issues/Antitrust/Workplace LBR

Issues related to the competitive nature of the pharmacy benefit manager industry and workforce issues. P.L. 119-21, The One Big, Beautiful Bill Act S. 2099, The Restore Prescription Drugs Discount Act

LobbyistCovered position, as disclosed
NICOLE BURDA —
JOY MCGLAUN —
SHANNON PENBERTHY —
AMY ROSENBAUM —
TARA ROUNTREE —
MELISSA SCHULMAN —
ROBERT TANNER WARBINTON —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 2099 (119th)

Consumer Issues/Safety/Products CSP

Issues related to organized retail crime. H.R. 2853/S. 1404, The Combatting Organized Retail Crime Act

LobbyistCovered position, as disclosed
SHANNON PENBERTHY —
ROBERT TANNER WARBINTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2853 (119th), S. 1404 (119th)

Advertising ADV

S. 2068 - The End Prescription Drugs Ads Now Act H.R. 3789 - The Drug-price Transparency for Consumers Act of 2025

LobbyistCovered position, as disclosed
JOY MCGLAUN —
SHANNON PENBERTHY —
AMY ROSENBAUM —

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3789 (119th), S. 2068 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.